Leaderboards/Metastasis and carcinoma case studies

Metastasis and carcinoma case studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Fabiana Lüönd
University of Basel
2
Qinru Zhan
Sun Yat-sen University
3
Greta Mattavelli
University of Würzburg
4
Ilona Krol
ETH Zurich
5
Zhenxiong Zhao
Shanghai Medical College of Fudan University
6
Jiawei Liu
Central South University
7
Kosuke Tanaka
Japanese Foundation For Cancer Research
8
Yi-Fu Chen
Chang Gung University
9
Louis‐Jean Masgnaux
Hospices Civils de Lyon
10
Yuting Pan
Renmin University of China

Papers

1
PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
MedComm|2025
13 cit.
2
C3+ cancer-associated fibroblasts promote tumor growth and therapeutic resistance in gastric cancer via activation of the NF-κB signaling pathway
Journal of Translational Medicine|2024
12 cit.
3
Energy insufficiency induced by high purine diet: Catalysts for renal impairment in hyperuricemia nephropathy rat model
Current Research in Food Science|2024
7 cit.
4
Publication in Human Vaccines & Immunotherapeutics (2024) [4 citations, W4403468865]
Human Vaccines & Immunotherapeutics|2024
4 cit.
5
Spatio-temporal dynamics, drivers and cross-media risks of antibiotic resistance in constructed wetland sediments
Bioresource Technology|2025
2 cit.
6
Publication in Endoscopy (2024) [1 citation, W4392766955]
Endoscopy|2024
1 cit.
7
Publication in Cell Communication and Signaling (2025) [W4414646118]
Cell Communication and Signaling|2025
0 cit.
8
Publication in Journal of Gastrointestinal Cancer (2026) [W7154845894]
Journal of Gastrointestinal Cancer|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Lenora A. Pluchino
National Comprehensive Cancer Network
2
Nami Sugiyama
University of Basel
3
Qingqing Ding
The University of Texas MD Anderson Cancer Center
4
Willem Jan van Weelden
Canisius-Wilhelmina Ziekenhuis
5
Jiexian Jing
Shanxi Provincial Cancer Hospital
6
Chao‐Hui Zheng
Fujian Medical University
7
Jane J. Liu
Sema4 (United States)
8
Lynn Hoang
Vancouver Coastal Health
9
Jiao Yang
Shanghai Sixth People's Hospital
10
Claudio Montero
University of Concepción

Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
3
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma
Human Pathology|2022
78 cit.
4
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.
5
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
Modern Pathology|2023
56 cit.
6
Expression of TRPS1 in phyllodes tumor and sarcoma of the breast
Human Pathology|2022
39 cit.
7
Prognostic impact of lymphovascular and perineural invasion in squamous cell carcinoma of the tongue
Scientific Reports|2023
34 cit.
8
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
PubMed|2022
32 cit.
9
Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis
European Journal of Surgical Oncology|2022
30 cit.
10
Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
Frontiers in Oncology|2022
28 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Aditya Bardia
UCLA Health
2
Daniel A. Haber
Howard Hughes Medical Institute
3
Shyamala Maheswaran
Massachusetts General Hospital
4
Jonathan A. Fletcher
Borders General Hospital
5
Timothy C. Wang
Columbia University
6
Yo Kato
Japanese Foundation For Cancer Research
7
Jerzy Lasota
National Institutes of Health
8
Norman Goldstein
University of Massachusetts Amherst
9
Cornelis J.�H. van de Velde
Leiden University Medical Center
10
Zena Werb
University of California, San Francisco

Papers

1
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
New England Journal of Medicine|2004
11.5k cit.
2
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
New England Journal of Medicine|2001
4.2k cit.
3
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Cell|2014
2.5k cit.
4
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Science|2013
2.5k cit.
5
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Journal of Clinical Oncology|2003
2.3k cit.
6
<i>PDGFRA</i> Activating Mutations in Gastrointestinal Stromal Tumors
Science|2003
2.3k cit.
7
Metastases in carcinoma.Analysis of 1000 autopsied cases
Cancer|1950
1.9k cit.
8
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers
Gastric Cancer|2000
1.8k cit.
9
Identification and characterization of essential genes in the human genome
Science|2015
1.8k cit.
10
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
Cell|1998
1.8k cit.

Reagents for Metastasis and carcinoma case studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Thermo Fisher ScientificEvidence 67

Vimentin Recombinant Rabbit Monoclonal Antibody (HL1506)

#MA5-56916
View Evidence →
Thermo Fisher ScientificEvidence 67

Vimentin Monoclonal Antibody (V9), Alexa Fluor 700

#56-9897-94
View Evidence →
Thermo Fisher ScientificEvidence 67

Vimentin Recombinant Mouse Monoclonal Antibody (V9)

#750013M
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

Cited in 5 papers
#A4502
View Evidence →
BD BiosciencesEvidence 62

N-Cadherin

#610920
View Evidence →
BD BiosciencesEvidence 62

E-Cadherin

#610182
View Evidence →